Sanofi has been granted a patent for an optical decoding system that uses an optical sensor to capture images of movable components in a drug delivery device to determine the amount of medicament dispensed. The system aims to improve accuracy and efficiency in medication dosing. GlobalData’s report on Sanofi gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Sanofi - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Sanofi, NSAID cancer drugs was a key innovation area identified from patents. Sanofi's grant share as of February 2024 was 61%. Grant share is based on the ratio of number of grants to total number of patents.

Optical decoding system for determining medicament dose in drug delivery device

Source: United States Patent and Trademark Office (USPTO). Credit: Sanofi

A recently granted patent (Publication Number: US11918788B2) discloses an optical decoding system designed for drug delivery devices. The system includes a single optical sensor integrated with or attachable to the device's housing, aimed at two or more movable components of the dose setting and dispensing mechanism. This sensor captures reflected light from these components, enabling the system to output signals based on the captured light. A processor receives these signals and determines crucial information related to the device's operation, distinguishing between dose dialing and dispensing modes based on the sensor's output.

Moreover, the system can identify encoded information associated with the movable components, determining their positions at the beginning and end of a dose dispensing process. This allows for the calculation of the amount of medication dispensed accurately. The system also features a display device to show the delivered medication amount. Additionally, the patent details the configuration of the movable components, such as a cylindrical sleeve with encoded information and a gear wheel with marked teeth. The optical sensor can be activated by the components' movement or a switch, ensuring precise decoding during the dose-setting and dispensing processes. This innovative optical decoding system enhances the functionality and accuracy of drug delivery devices, providing a reliable mechanism for monitoring and controlling medication dosages.

To know more about GlobalData’s detailed insights on Sanofi, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies